Vaccination can also lower your chances of other serious shingles complications. For example, if it shows up on your face, ...

Jefferies analyst Peter Welford downgraded GSK (GSK) to Hold from Buy with a price target of $39.50, down from $53. The firm ...

New study reveals potential cognitive benefits of Shingrix vaccine. The shingles shot may offer protection against dementia, especially in women.

As head of HHS, Kennedy would lead a sprawling federal department that encompasses more than 100 programs supporting medicine ...

Q3 2024 Earnings Call Transcript November 7, 2024Dynavax Technologies Corporation beats earnings expectations.

While GSK’s fundamental value remains compelling, overhangs for the company’s Arexvy and Shingrix vaccines, “more subdued” 2025 growth, and few near-term catalysts to “rebuild belief ...

The drugmaker’s U.S. plans comes on the heels of a rough quarter, with lower vaccine demand driving down Q3 sales by 15% year ...

The company has important products such as Shingrix and Arexvy in its vaccine segment. GSK also presents a strong portfolio of HIV and oncology therapeutics. I also believe that GSK has made some ...

It was the second dose, in which things seem to improve more for Shingrix than it did for us. It improved very well for both vaccines, but more for Shingrix. So, we're going to look at one dose.